trapidil has been researched along with Blood Clot in 5 studies
Trapidil: A coronary vasodilator agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We hypothesize that the utilization of trapidil-eluting DES in the setting of acute coronary syndromes will be characterized by a greater early re-endothelialization associated with an antiproliferative effect offering a similar efficacy with a better safety profile compared with first-generation DES." | 9.14 | Rationale and study design of the OISTER trial: optical coherence tomography evaluation of stent struts re-endothelialization in patients with non-ST-elevation acute coronary syndromes--a comparison of the intrEpide tRapidil eluting stent vs. taxus drug-e ( Iaccarino, D; Modena, MG; Monopoli, D; Politi, L; Rossi, R; Sangiorgi, GM; Sgura, F, 2010) |
| "We hypothesize that the utilization of trapidil-eluting DES in the setting of acute coronary syndromes will be characterized by a greater early re-endothelialization associated with an antiproliferative effect offering a similar efficacy with a better safety profile compared with first-generation DES." | 5.14 | Rationale and study design of the OISTER trial: optical coherence tomography evaluation of stent struts re-endothelialization in patients with non-ST-elevation acute coronary syndromes--a comparison of the intrEpide tRapidil eluting stent vs. taxus drug-e ( Iaccarino, D; Modena, MG; Monopoli, D; Politi, L; Rossi, R; Sangiorgi, GM; Sgura, F, 2010) |
| "Pretreatment of rats by the cyclooxygenase inhibitors diclofenac, phenylbutazone, and aminophenazone did not influence kappa-carrageenin (KC) rat tail thrombosis (RTT) whereas pretreatment by aspirin, at high doses, and particularly sulfinpyrazone decreased RTT frequency, PGI2 or iloprost i." | 3.67 | Role of eicosanoids in the kappa-carrageenin rat tail thrombosis. ( Bekemeier, H; Hirschelmann, R, 1988) |
| "Trapidil was expected to be an effective antithrombotic agent." | 1.26 | Antithrombotic activity and the mechanism of action of trapidil (Rocornal). ( Kitamura, Y; Ohnishi, H; Shimada, S; Suzuki, Y; Yamaguchi, K, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dodd, JM | 2 |
| McLeod, A | 2 |
| Windrim, RC | 2 |
| Kingdom, J | 2 |
| Iaccarino, D | 1 |
| Politi, L | 1 |
| Rossi, R | 1 |
| Sgura, F | 1 |
| Monopoli, D | 1 |
| Modena, MG | 1 |
| Sangiorgi, GM | 1 |
| Suzuki, Y | 1 |
| Yamaguchi, K | 1 |
| Shimada, S | 1 |
| Kitamura, Y | 1 |
| Ohnishi, H | 1 |
| Bekemeier, H | 1 |
| Hirschelmann, R | 1 |
2 reviews available for trapidil and Blood Clot
| Article | Year |
|---|---|
Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction.
Topics: Aspirin; Dipyridamole; Eclampsia; Female; Fibrinolytic Agents; Heparin; Humans; Infant; Infant, Low | 2013 |
Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction.
Topics: Dipyridamole; Eclampsia; Female; Fibrinolytic Agents; Heparin; Humans; Infant; Infant, Low Birth Wei | 2010 |
1 trial available for trapidil and Blood Clot
| Article | Year |
|---|---|
Rationale and study design of the OISTER trial: optical coherence tomography evaluation of stent struts re-endothelialization in patients with non-ST-elevation acute coronary syndromes--a comparison of the intrEpide tRapidil eluting stent vs. taxus drug-e
Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Biomarkers; Cardiac Catheterization; Cardio | 2010 |
2 other studies available for trapidil and Blood Clot
| Article | Year |
|---|---|
Antithrombotic activity and the mechanism of action of trapidil (Rocornal).
Topics: Adenosine Triphosphate; Animals; Aspirin; Blood Coagulation; Blood Platelets; Dipyridamole; Disease | 1982 |
Role of eicosanoids in the kappa-carrageenin rat tail thrombosis.
Topics: Aminopyrine; Animals; Aspirin; Benzydamine; Cardiovascular Agents; Carrageenan; Diclofenac; Epoprost | 1988 |